MORIX: Machine learning-aided framework for lethality detection and MORtality inference with eXplainable artificial intelligence in MAFLD subjects

Metabolic dysfunction-associated fatty liver disease (MAFLD) introduces new diagnostic criteria for fatty liver disease that are independent of alcohol consumption and viral hepatitis infection. Therefore, investigating how biochemical and anthropometric factors influence mortality in MAFLD subjects...

Full description

Saved in:
Bibliographic Details
Published inComputer methods and programs in biomedicine update Vol. 7; p. 100176
Main Authors Lofù, Domenico, Sorino, Paolo, Colafiglio, Tommaso, Bonfiglio, Caterina, Donghia, Rossella, Giannelli, Gianluigi, Lombardi, Angela, Di Noia, Tommaso, Di Sciascio, Eugenio, Narducci, Fedelucio
Format Journal Article
LanguageEnglish
Published Elsevier B.V 2025
Elsevier
Subjects
Online AccessGet full text
ISSN2666-9900
2666-9900
DOI10.1016/j.cmpbup.2024.100176

Cover

More Information
Summary:Metabolic dysfunction-associated fatty liver disease (MAFLD) introduces new diagnostic criteria for fatty liver disease that are independent of alcohol consumption and viral hepatitis infection. Therefore, investigating how biochemical and anthropometric factors influence mortality in MAFLD subjects is of significant interest. In this work, we propose MORIX, an Artificial Intelligence-based framework capable of predicting fatal mortality outcomes in subjects with MAFLD. MORIX utilizes data from epidemiological datasets containing carefully selected anthropometric and biochemical information. This selection is achieved through Recursive Feature Elimination (RFE) using a Random Forest (RF) to train Machine Learning (ML) algorithms and provide a mortality risk (Yes/No) output. To provide physicians with a valuable tool, MORIX was trained and tested on a dataset of MAFLD subjects, comparing five different models: Random Forest (RF), eXtreme Gradient Boosting (XGB), Support Vector Machine (SVM), Multilayer Perceptron (MLP), and Light Gradient Boosting Model (LGBM) in a 5-fold cross-validation training strategy. Experimental results identified the RF as the best model, achieving a high accuracy for both mortality risks predicted. Additionally, an eXplainable Artificial Intelligence (XAI) analysis was conducted to clarify the diagnostic logic of the RF model and to assess the impact of each feature to the prediction. Moreover, a web application was developed to predict mortality risk and provide explanations of how the input features influenced the final prediction. In conclusion, the MORIX framework is easy to apply, and the required parameters are readily available in healthcare datasets, making it a practical tool for medical professionals. •Introduced MORIX, an AI-based framework for predicting mortality in MAFLD patients.•Utilized Recursive Feature Elimination (RFE) with Random Forest (RF) to optimize feature selection.•Compared five ML models, with RF demonstrating the highest accuracy (83%) and AUC (0.88).•Applied eXplainable AI (XAI) methods to enhance model transparency and support clinical decision-making.•Developed a user-friendly web application for real-time mortality risk prediction and explanation.
ISSN:2666-9900
2666-9900
DOI:10.1016/j.cmpbup.2024.100176